Reata Pharmaceuticals Inc

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/10/2023

Shares

216,012

Value ($000)

22,025

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/10/2023	22,025	0.0%	216,012	6/30/2023
2023 Q1	5/12/2023	18,805	0.0%	206,825	3/31/2023
2022 Q4	2/13/2023	7,827	0.0%	206,020	12/31/2022
2022 Q3	11/14/2022	5,091	0.0%	202,559	9/30/2022
2022 Q2	8/15/2022	5,927	0.0%	195,010	6/30/2022
2022 Q1	5/13/2022	6,558	0.0%	200,153	3/31/2022
2021 Q4	2/11/2022	5,106	0.0%	193,627	12/31/2021
2021 Q3	11/16/2021	19,173	0.0%	190,564	9/30/2021
2021 Q2	8/16/2021	26,273	0.0%	185,635	6/30/2021
2021 Q1	5/17/2021	12,608	0.0%	126,450	3/31/2021
2020 Q4	2/16/2021	16,165	0.0%	130,758	12/31/2020
2020 Q3	11/13/2020	11,534	0.0%	118,386	9/30/2020
2020 Q2	8/20/2020	20,388	0.0%	130,671	6/30/2020
2020 Q1	5/15/2020	23,545	0.0%	163,119	3/31/2020
2019 Q4	2/7/2020	30,694	0.0%	150,141	12/31/2019